Literature DB >> 21374798

Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood.

Samir S Shah1, Matthew Hall, Jason G Newland, Thomas V Brogan, Reid W D Farris, Derek J Williams, Gitte Larsen, Bryan R Fine, James E Levin, Jeffrey S Wagener, Patrick H Conway, Angela L Myers.   

Abstract

OBJECTIVE: To determine the comparative effectiveness of common pleural drainage procedures for treatment of pneumonia complicated by parapneumonic effusion (ie, complicated pneumonia).
DESIGN: Multicenter retrospective cohort study.
SETTING: Forty children's hospitals contributing data to the Pediatric Health Information System. PARTICIPANTS: Children with complicated pneumonia requiring pleural drainage. MAIN EXPOSURES: Initial drainage procedures were categorized as chest tube without fibrinolysis, chest tube with fibrinolysis, video-assisted thoracoscopic surgery (VATS), and thoracotomy. MAIN OUTCOME MEASURES: Length of stay (LOS), additional drainage procedures, readmission within 14 days of discharge, and hospital costs.
RESULTS: Initial procedures among 3500 patients included chest tube without fibrinolysis (n = 1762), chest tube with fibrinolysis (n = 623), VATS (n = 408), and thoracotomy (n = 797). Median age was 4.1 years. Overall, 716 (20.5%) patients received an additional drainage procedure (range, 6.8-44.8% across individual hospitals). The median LOS was 10 days (range, 7-14 days across individual hospitals). The median readmission rate was 3.8% (range, 0.8%-33.3%). In multivariable analysis, differences in LOS by initial procedure type were not significant. Patients undergoing initial chest tube placement with or without fibrinolysis were more likely to require additional drainage procedures. However, initial chest tube without fibrinolysis was the least costly strategy.
CONCLUSION: There is variability in the treatment and outcomes of children with complicated pneumonia. Outcomes were similar in patients undergoing initial chest tube placement with or without fibrinolysis. Those undergoing VATS received fewer additional drainage procedures but had no differences in LOS compared with other strategies.
Copyright © 2011 Society of Hospital Medicine.

Entities:  

Mesh:

Year:  2011        PMID: 21374798      PMCID: PMC3112472          DOI: 10.1002/jhm.872

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  41 in total

1.  National hospitalization trends for pediatric pneumonia and associated complications.

Authors:  Grace E Lee; Scott A Lorch; Seth Sheffler-Collins; Matthew P Kronman; Samir S Shah
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

2.  Multiple regression of cost data: use of generalised linear models.

Authors:  Julie Barber; Simon Thompson
Journal:  J Health Serv Res Policy       Date:  2004-10

3.  Pleural empyema in children.

Authors:  Q R Stiles; G G Lindesmith; B L Tucker; B W Meyer; J C Jones
Journal:  Ann Thorac Surg       Date:  1970-07       Impact factor: 4.330

4.  Management of streptococcal empyema.

Authors:  D F Thomas; J L Glass; B F Baisch
Journal:  Ann Thorac Surg       Date:  1966-09       Impact factor: 4.330

5.  Randomised trial of intrapleural urokinase in the treatment of childhood empyema.

Authors:  A H Thomson; J Hull; M R Kumar; C Wallis; I M Balfour Lynn
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

6.  Experience with video-assisted thoracoscopic surgery in the management of complicated pneumonia in children.

Authors:  R Subramaniam; V T Joseph; G M Tan; A Goh; O M Chay
Journal:  J Pediatr Surg       Date:  2001-02       Impact factor: 2.545

7.  The controversial role of decortication in the management of pediatric empyema.

Authors:  A M Kosloske; K C Cartwright
Journal:  J Thorac Cardiovasc Surg       Date:  1988-07       Impact factor: 5.209

8.  Thoracoscopy in the management of empyema in children.

Authors:  J A Kern; B M Rodgers
Journal:  J Pediatr Surg       Date:  1993-09       Impact factor: 2.545

9.  Parapneumonic pleural effusion and empyema in children. Review of a 19-year experience, 1962-1980.

Authors:  T Chonmaitree; K R Powell
Journal:  Clin Pediatr (Phila)       Date:  1983-06       Impact factor: 1.168

10.  Intrapleural streptokinase for empyema and complicated parapneumonic effusions.

Authors:  Andreas H Diacon; Johan Theron; Macé M Schuurmans; Bernard W Van de Wal; Chris T Bolliger
Journal:  Am J Respir Crit Care Med       Date:  2004-03-24       Impact factor: 21.405

View more
  6 in total

1.  Cerebrospinal Fluid Findings Are Poor Predictors of Appropriate FilmArray Meningitis/Encephalitis Panel Utilization in Pediatric Patients.

Authors:  Mimi R Precit; Rebecca Yee; Utsav Pandey; Margil Fahit; Cheryl Pool; Samia N Naccache; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2020-02-24       Impact factor: 5.948

2.  Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.

Authors:  Andrew D Wiese; Marie R Griffin; Yuwei Zhu; Edward F Mitchel; Carlos G Grijalva
Journal:  Vaccine       Date:  2016-11-07       Impact factor: 3.641

3.  Making the transition from video-assisted thoracoscopic surgery to chest tube with fibrinolytics for empyema in children: Any change in outcomes?

Authors:  Michael H Livingston; Sara Colozza; Kelly N Vogt; Neil Merritt; Andreana Bütter
Journal:  Can J Surg       Date:  2016-06       Impact factor: 2.089

4.  Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation.

Authors:  Chris Feudtner; James A Feinstein; Wenjun Zhong; Matt Hall; Dingwei Dai
Journal:  BMC Pediatr       Date:  2014-08-08       Impact factor: 2.125

5.  Antibiotics for Aspiration Pneumonia in Neurologically Impaired Children.

Authors:  Joanna Thomson; Matt Hall; Lilliam Ambroggio; Jay G Berry; Bryan Stone; Rajendu Srivastava; Samir S Shah
Journal:  J Hosp Med       Date:  2019-11-20       Impact factor: 2.960

Review 6.  Existing data analysis in pediatric critical care research.

Authors:  Tellen D Bennett; Michael C Spaeder; Renée I Matos; R Scott Watson; Katri V Typpo; Robinder G Khemani; Sheri Crow; Brian D Benneyworth; Ravi R Thiagarajan; J Michael Dean; Barry P Markovitz
Journal:  Front Pediatr       Date:  2014-07-29       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.